NCT03710382 is a NA clinical trial of Walking epidural in Labor Pain, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

Who is sponsoring NCT03710382?

NCT03710382 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

What drugs are being tested in NCT03710382?

Interventions in NCT03710382: Walking epidural.

What condition does NCT03710382 study?

NCT03710382 studies Labor Pain.

Is NCT03710382 still recruiting?

NCT03710382 is currently completed. Last updated 26 March 2019.

Last reviewed 2019-03-26 · How we verify

NCT03710382

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The WE Pilot Study: Walking Epidurals

Completed NA Last updated 26 March 2019

What this trial tests

NA trial testing Walking epidural in Labor Pain in 30 participants. Completed in 22 March 2019.

Timeline

14 January 2019

Primary endpoint
22 March 2019

22 March 2019

Quick facts

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	30
Start date	14 January 2019
Primary completion	22 March 2019
Estimated completion	22 March 2019
Sites	1 location across Canada

Drugs / interventions tested

Walking epidural

Conditions studied

Labor Pain — all drugs for Labor Pain →

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Who can join

18 and older, female only, with Labor Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to assess the feasibility of a walking epidural protocol in our center. This study will provide a small data set for a larger prospective randomized controlled study. Hypothesis: Walking a minimum of 15 minutes per hour will decrease the incidence of instrumental deliveries (forceps and vacuum) in women presenting in spontaneous or induced labor with neuraxial analgesia. Before testing this hypothesis in a randomized controlled study, the feasibility of this protocol needs to be assessed since allowing laboring women to ambulate while receiving neuraxial analgesia is not the standard-of-care at our institution.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Labor Pain

Currently open trials in the same condition.

NCT07440069 — Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor · Phase 4 · recruiting
NCT07411352 — Left Lateral Position vs Supine Position to Reduce Active Labor Duration · NA · recruiting
NCT07401147 — Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor. · NA · recruiting
NCT07395934 — Comparing PIEB and CEI for Labor Pain Relief · NA · recruiting
NCT06819579 — Exploring the Optimal Concentration of Lidocaine Test Dose for Labor Analgesia · NA · active not recruiting

Other Centre hospitalier de l'Université de Montréal (CHUM) trials

Trials by the same sponsor.

NCT06735638 — Outside the Cage (OTC) Robotic Esophagectomy · Phase 1 · not yet recruiting
NCT07533253 — Rescue Distal Thrombectomy in Treatment for Persistent Distal Occlusions · NA · not yet recruiting
NCT05225272 — Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery · not yet recruiting
NCT07497061 — Comparison of Two Surgical Techniques for the Treatment of Trigger Fingers: Longitudinal Opening Versus Complete A1 Pull · NA · not yet recruiting
NCT07196410 — KAN-004 for Immune-Related Diarrhea or Colitis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03710382 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM)
Last refreshed: 26 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03710382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing